A meta-analysis of the efficacy and safety of using infliximab for the treatment of rheumatoid arthritis

Clinical Rheumatology

Volumn 28, Issue 12, 2009, Pages 1365-1373

  Wiens, Astrid ^a   Correr, Cassyano Januário ^a   Venson, Rafael ^a   Grochocki, Mônica Cavichiolo ^b   Otuki, Michel Fleith ^c   Pontarolo, Roberto ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Section of Venomous Animals   (Brazil)

^c STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

Author keywords

Efficacy and safety; Infliximab; Meta analysis; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HUMAN; INFECTION; INJECTION SITE REACTION; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; INFUSIONS, INTRAVENOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70450277098     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1233-9     Document Type: Article

References (30)

1. P Tugwell 2000 Pharmacoeconomics of drug therapy for rheumatoid arthritis Rheumatology (Oxford) 39 Suppl 1 43 47
2. ML Moss L Sklair-Tavron R Nudelman 2008 Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis Nat Clin Pract Rheumatol 4 6 300 309 10.1038/ncprheum0797 1:CAS:528: DC%2BD1cXmsFyktrg%3D 18414459 (Pubitemid 351791441)
3. L Klareskog D van der Heijde JP de Jager A Gough J Kalden M Malaise, et al. 2004 Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial Lancet 363 9410 675 681 10.1016/S0140-6736(04)15640-7 1:CAS:528:DC%2BD2cXhs12jur4%3D 15001324 (Pubitemid 38296553)
4. M Bértolo C Brenol C Schainberg F Neubarth 2007 Atualização do consenso brasileiro no diagnóstico e tratamento da artrite reumatóide Rev Bras Reumatol 47 3 151 159
5. A Fernandez-Nebro MV Irigoyen I Urena MA Belmonte-Lopez V Coret FG Jimenez-Nunez, et al. 2007 Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis J Rheumatol 34 12 2334 2342 1:CAS:528: DC%2BD1cXotlGgsg%3D%3D 17985409
6. K Kanbe K Inoue Y Inoue Y Suzuki 2008 Histological changes in bone marrow after treatment of infliximab for rheumatoid arthritis Clin Rheumatol 27 4 497 501 10.1007/s10067-007-0790-z 18060342
7. R Maini EW St Clair F Breedveld D Furst J Kalden M Weisman, et al. 1999 Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group Lancet 354 9194 1932 1939 10.1016/S0140-6736(99)05246-0 1:CAS:528:DC%2BD3cXit1Oquw%3D%3D 10622295
8. JS Smolen C Han M Bala RN Maini JR Kalden D van der Heijde, et al. 2005 Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study Arthritis Rheum 52 4 1020 1030 10.1002/art.20982 1:CAS:528:DC%2BD2MXktFCksbk%3D 15818697 (Pubitemid 40530107)
9. FC Breedveld P Emery E Keystone K Patel DE Furst JR Kalden, et al. 2004 Infliximab in active early rheumatoid arthritis Ann Rheum Dis 63 149 155 10.1136/ard.2003.013961 1:CAS:528:DC%2BD2cXhsVGnsLY%3D 14722203 (Pubitemid 38122133)
10. DM Lee ME Weinblatt 2001 Rheumatoid arthritis Lancet 358 9285 903 911 10.1016/S0140-6736(01)06075-5 1:CAS:528:DC%2BD3MXmvVKmtr8%3D 11567728 (Pubitemid 32900579)
11. RG Silva AB Vannucci LC Latorre CAF Zerbini 2003 Artrite reumatóide Rev Bras Med 60 8 554 577
12. E Zintzaras IJ Dahabreh S Giannouli M Voulgarelis HM Moutsopoulos 2008 Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens Clin Ther 30 11 1939 1955 10.1016/j.clinthera.2008.11.007 1:CAS:528:DC%2BD1MXhsV2guro%3D 19108784
13. EW St Clair DM van der Heijde JS Smolen RN Maini JM Bathon P Emery, et al. 2004 Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial Arthritis Rheum 50 11 3432 3443 10.1002/art.20568 1:CAS:528:DC%2BD2cXhtVOqtrvJ 15529377 (Pubitemid 39488667)
14. T Abe T Takeuchi N Miyasaka H Hashimoto H Kondo Y Ichikawa, et al. 2006 A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis J Rheumatol 33 1 37 44 1:CAS:528:DC%2BD28Xps1ajug%3D%3D 16395748
15. PE Lipsky DM van der Heijde EW St Clair DE Furst FC Breedveld JR Kalden, et al. 2000 Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group N Engl J Med 343 22 1594 1602 10.1056/NEJM200011303432202 1:CAS:528:DC%2BD3cXovVeltLk%3D 11096166 (Pubitemid 32162982)
16. M Schiff M Keiserman C Codding S Songcharoen A Berman S Nayiager, et al. 2008 Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate Ann Rheum Dis 67 8 1096 1103 10.1136/ard.2007.080002 1:CAS:528: DC%2BD1cXhtVSktbvJ 18055472
17. R Westhovens D Yocum J Han A Berman I Strusberg P Geusens, et al. 2006 The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial Arthritis Rheum 54 4 1075 1086 10.1002/art.21734 1:CAS:528:DC%2BD28XksVyht7s%3D 16572442 (Pubitemid 43672920)
18. F-C Zhang Y Hou F Huang D-H Wu C-D Bao L-Q Ni, et al. 2006 Infliximab versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a preliminary study from China APLAR J Rheumatol 9 2 127 130 10.1111/j.1479-8077.2006.00186.x (Pubitemid 44057326)
19. PC Taylor A Steuer J Gruber DO Cosgrove MJ Blomley PA Marsters, et al. 2004 Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis Arthritis Rheum 50 4 1107 1116 10.1002/art.20123 1:STN:280:DC%2BD2c7otVGqtg%3D%3D 15077292 (Pubitemid 38480820)
20. AR Jadad RA Moore D Carroll C Jenkinson DJ Reynolds DJ Gavaghan, et al. 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 1 12 10.1016/0197-2456(95)00134-4 1:STN:280:DyaK28zgvVCmug%3D%3D 8721797 (Pubitemid 26120810)
21. DT Felson JJ Anderson M Boers C Bombardier D Furst C Goldsmith, et al. 1995 American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 6 727 735 10.1002/art.1780380602 1:STN:280:DyaK2M3pvVSmtA%3D%3D 7779114
22. A Hakkinen H Kautiainen P Hannonen J Ylinen H Makinen T Sokka 2006 Muscle strength, pain, and disease activity explain individual subdimensions of the Health Assessment Questionnaire disability index, especially in women with rheumatoid arthritis Ann Rheum Dis 65 1 30 34 10.1136/ard.2004.034769 1:STN:280:DC%2BD2MnmtFCgsw%3D%3D 15901635 (Pubitemid 41819020)
23. TB Huedo-Medina J Sanchez-Meca F Marin-Martinez J Botella 2006 Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11 2 193 206 10.1037/1082-989X.11.2.193 16784338 (Pubitemid 44001277)
24. MA Quinn PG Conaghan PJ O'connor Z Karim A Greenstein A Brown, et al. 2005 Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial Arthritis Rheum 52 1 27 35 10.1002/art.20712 1:CAS:528:DC%2BD2MXht1KisLY%3D 15641102 (Pubitemid 40129229)
25. JS Smolen DM van der Heijde EW St Clair P Emery JM Bathon E Keystone, et al. 2006 Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial Arthritis Rheum 54 3 702 710 10.1002/art.21678 1:CAS:528:DC%2BD28XjtV2ls74%3D 16508926
26. Food and Drug Administration (2006) Arthritis Drugs Advisory Committee: Safety update on TNF antagonists: infliximab and etanercept. http://wwwfdagov/medwatch/SAFETY/2006/May-PIs/Remicade-PIpdfhttp://wwwfdagov/ medwatch/SAFETY/2006/May-PIs/Remicade-PIpdf
27. WG Dixon K Watson M Lunt KL Hyrich AJ Silman DP Symmons 2006 Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register Arthritis Rheum 54 8 2368 2376 10.1002/art.21978 1:CAS:528:DC%2BD28XpsFGgu7g%3D 16868999 (Pubitemid 44204996)
28. J Keane S Gershon RP Wise E Mirabile-Levens J Kasznica WD Schwieterman, et al. 2001 Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 15 1098 1104 10.1056/NEJMoa011110 1:CAS:528:DC%2BD3MXnsFShsr0%3D 11596589 (Pubitemid 34940777)
29. B van der Cruyssen S Van Looy B Wyns R Westhovens P Durez F Van den Bosch, et al. 2006 Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity Arthritis Res Ther 8 4 R112 10.1186/ar2001
30. K Pavelka K Jarosova D Suchy L Senolt K Chroust L Dusek, et al. 2009 Increasing the infliximab dose in rheumatoid arthritis patients: a randomized, double blind study failed to confirm its efficacy Ann Rheum Dis 68 1285 1289 10.1136/ard.2008.090860 1:CAS:528:DC%2BD1MXhtFGqsrvO 19351624